• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计一种新型 Fab 样抗体片段,提高其稳定性和临床应用亲和力。

Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use.

机构信息

MOE/NHC Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

Department of Ophthalmology and Vision Science, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, 200031, China.

出版信息

Small Methods. 2022 Feb;6(2):e2100966. doi: 10.1002/smtd.202100966. Epub 2021 Nov 28.

DOI:10.1002/smtd.202100966
PMID:35174992
Abstract

With increasing interest in applying recombinant monoclonal antibodies (mAbs) in human medicine, engineered mAb fragments with reduced size and improved stability are in demand to overcome current limitations in clinical use. Herein, a novel Fab-like antibody fragment generated via an in silico-based engineering approach where the CH1 and CL domains of Fab are replaced by the IgG1 CH3 domains is described. This construct, designated as FabCH3, maintains the natural N-terminus and C-terminus of IgG antibody, can be expressed at a high level in bacterial cells and, importantly, exhibits much higher stability and affinity than the parental Fab when tested in a mesothelin-specific Fab m912, as well as a vascular endothelial growth factor A (VEGFA)-specific Fab Ranibizumab (in vivo). The high-resolution crystal structures of m912 FabCH3 and m912 Fab are determined, and the comparative analysis reveals more rigid structures in both constant domains and complementarity-determining regions of FabCH3, explaining its enhanced stability and affinity. Overall, the stabilized FabCH3 described in this report provides a versatile platform for engineering Fab-like antibody fragments with higher stability and antigen-binding affinity that can be used as a distinct class of antibody therapeutics.

摘要

随着人们对将重组单克隆抗体 (mAb) 应用于人类医学的兴趣日益浓厚,需要具有更小尺寸和更高稳定性的工程化 mAb 片段来克服当前临床应用中的限制。在此,描述了一种通过基于计算的工程方法产生的新型 Fab 样抗体片段,其中 Fab 的 CH1 和 CL 结构域被 IgG1 的 CH3 结构域取代。该构建体被命名为 FabCH3,保留了 IgG 抗体的天然 N 端和 C 端,能够在细菌细胞中高水平表达,并且在测试时表现出比亲本 Fab 更高的稳定性和亲和力,特别是在针对间皮素的 Fab m912 以及针对血管内皮生长因子 A (VEGFA) 的 Fab Ranibizumab(体内)。确定了 m912 FabCH3 和 m912 Fab 的高分辨率晶体结构,比较分析表明 FabCH3 的恒定结构域和互补决定区的结构更加刚性,解释了其增强的稳定性和亲和力。总体而言,本报告中描述的稳定化 FabCH3 为工程化具有更高稳定性和抗原结合亲和力的 Fab 样抗体片段提供了一个多功能平台,可作为一类独特的抗体治疗药物。

相似文献

1
Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use.设计一种新型 Fab 样抗体片段,提高其稳定性和临床应用亲和力。
Small Methods. 2022 Feb;6(2):e2100966. doi: 10.1002/smtd.202100966. Epub 2021 Nov 28.
2
Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.一种优化抗VEGF抗体的筛选与分析:亲和力成熟的Fab与抗原复合物的晶体结构
J Mol Biol. 1999 Nov 5;293(4):865-81. doi: 10.1006/jmbi.1999.3192.
3
Interaction between the antigen and antibody is controlled by the constant domains: normal mode dynamics of the HEL-HyHEL-10 complex.抗原与抗体之间的相互作用由恒定结构域控制:HEL-HyHEL-10复合物的正常模式动力学。
Protein Sci. 2003 Oct;12(10):2125-31. doi: 10.1110/ps.03100803.
4
Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors.新型双 Fc 抗体的设计与鉴定,增强了对 Fc 受体的亲和力。
Proteins. 2020 May;88(5):689-697. doi: 10.1002/prot.25853. Epub 2019 Nov 20.
5
Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.单链抗体及单克隆抗体4-4-20的Fv衍生物的比较特性。结构域间相互作用与对荧光素配体的高亲和力之间的关系。
J Biol Chem. 1996 Mar 8;271(10):5338-46. doi: 10.1074/jbc.271.10.5338.
6
Structure-based stability engineering of the mouse IgG1 Fab fragment by modifying constant domains.通过修饰恒定结构域对小鼠IgG1 Fab片段进行基于结构的稳定性工程改造。
J Mol Biol. 2006 Aug 25;361(4):687-97. doi: 10.1016/j.jmb.2006.06.073. Epub 2006 Jul 28.
7
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.SEED 疗法评估:一种新型工程抗体平台,旨在生成单特异性和双特异性抗体。
Protein Eng Des Sel. 2011 May;24(5):447-54. doi: 10.1093/protein/gzq123.
8
Efficient secretion of murine Fab fragments by Escherichia coli is determined by the first constant domain of the heavy chain.大肠杆菌对鼠源Fab片段的高效分泌由重链的第一个恒定结构域决定。
Gene. 1993 Jun 30;128(2):203-9. doi: 10.1016/0378-1119(93)90564-j.
9
An antibody with Fab-constant domains exchanged for a pair of CH3 domains.一种 Fab 恒定结构域被一对 CH3 结构域替换的抗体。
PLoS One. 2018 Apr 9;13(4):e0195442. doi: 10.1371/journal.pone.0195442. eCollection 2018.
10
Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.IgG1抗体中电荷介导的Fab-Fc相互作用会诱导可逆的自缔合、聚集体形成以及粘度升高。
MAbs. 2016 Nov/Dec;8(8):1561-1574. doi: 10.1080/19420862.2016.1222342. Epub 2016 Aug 25.

引用本文的文献

1
Modeling the Ocular Pharmacokinetics and Pharmacodynamics of Ranibizumab for Improved Understanding and Data Collection Strategies in Ocular Diseases.模拟雷珠单抗的眼药代动力学和药效学以增进对眼部疾病的理解并改进数据收集策略
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):20. doi: 10.1167/iovs.66.6.20.
2
TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma.TFAB002s,新型靶向 CD20 的 T 细胞依赖性双特异性 Fab-FabCH3 抗体,对恶性 B 细胞淋巴瘤表现出强大的抗肿瘤疗效。
PLoS One. 2024 Sep 25;19(9):e0310889. doi: 10.1371/journal.pone.0310889. eCollection 2024.
3
NANOBODY Molecule, a Giga Medical Tool in Nanodimensions.
纳米无人分子,纳米维度的医疗巨擘。
Int J Mol Sci. 2023 Aug 25;24(17):13229. doi: 10.3390/ijms241713229.